NXTC Earnings NextCure, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–26 of 26
| Q2 2026 | 2026-06-30 | -4.68 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.87 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -19.65 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -18.84 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | -16.05 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -4.70 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -23.88 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -18.91 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -13.96 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.61 | 2025-05-01 | 10-Q |
| FY 2024 | 2023-12-31 | -2.25 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | -1.73 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.22 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.58 | 2024-05-02 | 10-Q |
| FY 2023 | 2022-12-31 | -2.69 | 2024-03-21 | 10-K |
| Q3 2023 | 2022-09-30 | -2.07 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.39 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.74 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -2.51 | 2023-03-02 | 10-K |
| Q3 2022 | 2021-09-30 | -1.90 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.25 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.60 | 2022-05-05 | 10-Q |
| FY 2021 | 2020-12-31 | -1.33 | 2022-03-03 | 10-K |
| Q3 2021 | 2020-09-30 | -0.77 | 2021-11-04 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.33 | 2021-05-06 | 10-Q |
| Q1 2020 | 2019-03-31 | -4.46 | 2020-05-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.